UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6226
Corvus Pharmaceuticals
CRVS
$1.17B
| $279K | ﹤0.01% |
52,109
+36,428
| +232% | +$272K |
|
|
ACTV
6227
DELISTED
LeaderShares Activist Leaders ETF
ACTV
| $279K | ﹤0.01% |
8,563
+6,892
| +412% | +$230K |
|
6228
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $277K | ﹤0.01% |
2,833
-1
| -0% | -$101 |
|
6229
Matthews China Active ETF
MCH
$23.4M
| $277K | ﹤0.01% |
12,563
-1,008
| -7% | -$23.9K |
|
|
MHF
6230
Western Asset Municipal High Income Fund
MHF
$153M
| $277K | ﹤0.01% |
40,737
-11,231
| -22% | -$79.7K |
|
6231
Backblaze
BLZE
$1.16B
| $277K | ﹤0.01% |
45,979
+20,728
| +82% | +$141K |
|
6232
NetSol Technologies
NTWK
$50.6M
| $277K | ﹤0.01% |
105,547
+99,223
| +1,569% | +$285K |
|
|
JWN
6233
CALL
DELISTED
Nordstrom
JWN
| $276K | ﹤0.01% |
11,440
-78,020
| -87% | -$1.8M |
|
6234
Bioceres Crop Solutions
BIOX
$22M
| $276K | ﹤0.01% |
45,429
+30,717
| +209% | +$210K |
|
6235
John Wiley & Sons Class B
WLYB
$2.73B
| $276K | ﹤0.01% |
6,335
+435
| +7% | +$21.3K |
|
6236
Douglas Elliman
DOUG
$162M
| $276K | ﹤0.01% |
165,080
+146,524
| +790% | +$282K |
|
6237
Concrete Pumping Holdings
BBCP
$491M
| $275K | ﹤0.01% |
41,335
+21,274
| +106% | +$131K |
|
6238
Amplify Energy & Natural Resources Covered Call ETF
NDIV
$26.5M
| $275K | ﹤0.01% |
9,950
+2,005
| +25% | +$57.5K |
|
6239
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$766M
| $274K | ﹤0.01% |
+2,953
| New | +$247K |
|
|
SRDX
6240
DELISTED
Surmodics
SRDX
| $274K | ﹤0.01% |
6,907
+3,374
| +95% | +$131K |
|
6241
Inhibrx
INBX
$1.3B
| $273K | ﹤0.01% |
17,757
+11,716
| +194% | +$178K |
|
6242
Oramed Pharmaceuticals
ORMP
$179M
| $273K | ﹤0.01% |
112,981
+84,797
| +301% | +$202K |
|
6243
Core Molding Technologies
CMT
$234M
| $273K | ﹤0.01% |
16,529
+8,740
| +112% | +$144K |
|
6244
ECARX Holdings
ECX
$432M
| $273K | ﹤0.01% |
129,340
+125,847
| +3,603% | +$232K |
|
6245
Freedom 100 Emerging Markets ETF
FRDM
$3.35B
| $273K | ﹤0.01% |
+8,344
| New | +$289K |
|
|
WCC
6246
PUT
WESCO International
WCC
$17.7B
| $271K | ﹤0.01% |
1,500
| – | – |
|
|
HTB
6247
HomeTrust Bancshares
HTB
$848M
| $271K | ﹤0.01% |
8,058
-301
| -4% | -$10.6K |
|
|
IONQ.WS
6248
IonQ Inc Warrants
IONQ.WS
$8.06B
| $271K | ﹤0.01% |
8,906
+6,190
| +228% | +$91.8K |
|
6249
Sierra Bancorp
BSRR
$525M
| $271K | ﹤0.01% |
9,378
+1,787
| +24% | +$53.5K |
|
6250
VanEck ChiNext Innovators ETF
CNXT
$110M
| $271K | ﹤0.01% |
9,847
+9,752
| +10,265% | +$291K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.